Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

U.S. stocks open higher with eyes on Yellen, Ukraine; Dow Jones up 0.38%

Published 05/07/2014, 09:41 AM
U.S. stocks rise on Ukraine hopes, Yellen testimony ahead

Investing.com - U.S. stocks opened higher on Wednesday, as investors awaited testimony from Federal Reserve Chair Janet Yellen scheduled later in the day, while they continued to monitor events in Ukraine.

During early U.S. trade, the Dow 30 rose 0.38%, the S&P 500 added 0.30%, while the NASDAQ Composite inched up 0.04%.

In testimony to Congress later Wednesday, Ms. Yellen was widely expected to reiterate interest rates will remain on hold for longer, in spite of last month’s stronger-than-forecast U.S. nonfarm payrolls report.

Meanwhile, concerns over the crisis in Ukraine still weighed on market sentiment, as conflict between the government and pro-Russian separatists in the east and south of the country continued to escalate, fuelling fears over a civil war.

Sentiment improved however, as Russian President Vladimir Putin said he was ready to discuss a way out of the Ukrainian crisis with the head of the Organization for Security and Co-operation in Europe.

In the financial sector, Goldman Sachs (NYSE:GS) jumped 1.04% following reports it completed fundraising for its second real estate credit pool at $4.2 billion. The bank shifted its real estate focus to lending from buying properties after the financial crisis.

Adding to gains, Walt Disney Company (NYSE:DIS) rallied 1.67% after reporting late Tuesday second-quarter net income of $1.92 billion, or $1.08 a share, exceeding analysts’ estimates. The company also said that sales grew to $11.6 billion, beating projections of $11.2 billion.

Meanwhile, Caesars Entertainment (NASDAQ:CZR) skyrocketed 19.77% after saying that it is selling a minority interest in its largest unit. The decision is set to remove guarantees by the casino company on much of its $23 billion of debt and to set the stage for a wider restructuring.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the downside, Merck & Company (NYSE:MRK) saw shares drop 0.57% a day after Bayer (XETRA:BAYGN) agreed to pay $14.2 billion for a number of the U.S. pharmaceutical giant's over-the-counter products.

Other stocks likely to be in focus included Tesla Motors (NASDAQ:TSLA), Chesapeake Energy (NYSE:CHK), Allergan (NYSE:AGN) and Hertz Global (NYSE:HTZ), scheduled to report quarterly results later in the day.

Across the Atlantic, European stock markets were mixed to higher. The DJ Euro Stoxx 50 rose 0.27%, France’s CAC 40 gained 0.33%, Germany's DAX advanced 0.54%, while Britain's FTSE 100 fell 0.22%.

During the Asian trading session, Hong Kong's Hang Seng tumbled 1.05%, while Japan’s Nikkei 225 plunged 2.93%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.